Top news of the week: 15.04.2021.
Startups
Biotech R&D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO
Sajith Wickramasekara was just 24 when he got on Forbes 30 Under 30 list for his biotech R&D startup Benchling. Now his company is worth $4 billion with a new $200 million round led by ...
Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane
Roche’s gene therapy unit Spark Therapeutics has penned a $645 million-plus biobucks pact with Bayer-backed Senti Biosciences for new tech aimed at tweaking next-gen gene therapies.
Timmerman Traverse for LSC: A Biotech Community Drive to Fight Poverty
Like many people, I’m itching to get outside. Today, I’m excited to announce a new outdoor experience for a good cause: The Timmerman Traverse for Life Science Cares. It’s a Presidential ...
Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO
After banking $72 million at the start of the year, Werewolf Therapeutics now wants an IPO.
Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar
Just two months after launching, Jaguar Gene Therapy has raised another $139 million for a preclinical pipeline aimed at gene-linked autism and diabetes.
M2D2 $200K Challenge Names Pitch Contest Winners
A biotech startup that aims to transform how intravenous medications are administered to patients is the top winner in the 2021 Massachusetts Medical Device Development Center (M2D2) $200K ...
Episode 119: Bobby Franklin
Bobby Franklin is the president and CEO of National Venture Capital Association, which advocates for public policy that supports the American entrepreneurial ecosystem.
See the presentations that hot healthcare and biotech startups used to raise millions from top VCs
We compiled the pitch decks that healthcare and biotech startups like Cedar, Moderna, and Devoted Health have used to win over investors.